News

Emergent executes Letter of Intent with Regen Biowellness, Inc.; Former L’Oréal President Jim Morrison to join Emergents Management Team

HAUPPAUGE, NY / ACCESSWIRE / July 6, 2022 / Emergent Health Corp. ("Emergent") (OTC PINK:EMGE) announces it has executed a…

2 years ago

Cosmos Holdings to Acquire LIFE NLB Portfolio of Bone Health Products that Target the Gastrointestinal Microbiome

Acquisition will include all launched and under development bone health productsCHICAGO, IL / ACCESSWIRE / July 6, 2022 / Cosmos…

2 years ago

9 Meters Biopharma to Participate in the William Blair Biotech Focus Conference 2022

RALEIGH, NC / ACCESSWIRE / July 6, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments…

2 years ago

Jupiter Wellness Developing Novel Women’s Sexual Health Product

JUPITER, FL / ACCESSWIRE / July 6, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it is developing RJ-101 a…

2 years ago

Avinger Announces Filing of 510(k) Submission for Tigereye ST Image-Guided CTO Crossing System

REDWOOD CITY, CA / ACCESSWIRE / July 6, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the…

2 years ago

Dynatronics Announces Appointment of New Chief Information Officer; Krier to add Chief Financial Officer Responsibilities

Senior leadership realignment focused on continuing to deliver sales growth and enhanced profitability.EAGAN, MN / ACCESSWIRE / July 6, 2022…

2 years ago

MCOA Subsidiary cDistro Signs Master Distribution with Mellow to Distribute Dosist brand in Europe

LOS ANGELES, CA / ACCESSWIRE / July 6, 2022 / Marijuana Company of America, Inc. (OTC:MCOA) ("the Company"), which operates,…

2 years ago

Clairvoyant Therapeutics: Clairvoyant Initiates First Site for Phase 2 Psilocybin Therapy Clinical Trial for Alcohol Use Disorder

VANCOUVER, BC / ACCESSWIRE / July 6, 2022 / Clairvoyant Therapeutics, a Canadian biotech company, is pleased to announce it…

2 years ago

Pressure BioSciences to Expand on Upcoming Release of CBD Nanoemulsion Oral Spray at July 6th Emerging Growth Conference – Annual Revenue to PBI Expected to Exceed $1M

Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive Update/Q&A SessionSOUTH EASTON, MA / ACCESSWIRE / July 6,…

2 years ago

Clairvoyant Initiates First Site for Phase 2 Psilocybin Therapy Clinical Trial for Alcohol Use Disorder

VANCOUVER, BC / ACCESSWIRE / July 6, 2022 / Clairvoyant Therapeutics, a Canadian biotech company, is pleased to announce it…

2 years ago